Ann: Trial on the Effect of CannEpil on Driver Competency, page-13

I did not expect this to move the SP - it is more future orientated but it will benefit MXC to have a successful trial - and that will make more doctors willing to prescribe CannEpil down the track. Another string in the bow for 202 sort of thing.

In any case, I am actually surprised the SP has not been forced down to the CR asking price of 4 cents. BOTS and day traders are falling down on the job. I do expect it to fall to 4 cents otherwise we will get a string of sell orders in at 4.5 cents after shareholders picked up shares at 4 cents.

So, get ready for the SP to soften a bit more in the near future.